Charles River Laboratories International (NYSE:CRL) Stock Rating Upgraded by TD Cowen
TD Cowen upgraded shares of Charles River Laboratories International (NYSE:CRL – Free Report) from a hold rating to a buy rating in a research note issued to investors on Wednesday morning, MarketBeat.com reports. They currently have $179.00 price objective on the medical research company’s stock. A number of other equities analysts have also recently weighed […]
TD Cowen upgraded shares of Charles River Laboratories International (NYSE:CRL – Free Report) from a hold rating to a buy rating in a research note issued to investors on Wednesday morning, MarketBeat.com reports. They currently have $179.00 price objective on the medical research company’s stock. A number of other equities analysts have also recently weighed […]
